| Literature DB >> 32761863 |
Aniket Nadkarni1, Steven Alderson1, Luke Collett1, Matthew Maiden1, Benjamin Reddi1, Krishnaswamy Sundararajan1.
Abstract
The scale of the COVID-19 pandemic represents unprecedented challenges to healthcare systems. We describe a cohort of 18 critically ill COVID-19 patients - to our knowledge the highest number, in a single intensive care unit in Australia. We discuss the complex challenges and dynamic solutions that concern an intensive care unit pandemic response. Acting as the State's COVID-19 referral hospital, we provide local insights to consider alongside national guidelines.Entities:
Keywords: COVID-19; critical care; intensive care unit; pandemic
Mesh:
Year: 2020 PMID: 32761863 PMCID: PMC7436578 DOI: 10.1111/imj.14963
Source DB: PubMed Journal: Intern Med J ISSN: 1444-0903 Impact factor: 2.611
Clinical characteristics, ICU therapies and outcomes
| Characteristic | Patients ( |
|---|---|
| Median age (IQR) (years) | 67 (60–73) |
| Sex, | |
| Male | 14 (78) |
| Female | 4 (22) |
| ICU therapy | |
| High‐flow nasal oxygen | 14/18 (78) |
| Non‐invasive ventilation | 0/18 |
| Invasive mechanical ventilation | 8/18 (44) |
| Prone positioning | 5/8 (63) |
| Extracorporeal membrane oxygenation | 0/18 |
| Vasoactive therapy | 11/18 (61) |
| Continuous renal‐replacement therapy | 4/18 (22) |
| Outcomes | |
| Median length of stay (IQR) (days) | |
| In hospital | 13 (11–17) |
| In ICU | 4 (2–14) |
| In hospital, survivors | 13 (10–25) |
| In ICU, survivors | 3(2–14) |
| Median duration of mechanical ventilation (IQR), (days) | 11 (8–13) |
| Extubation, | 3/8 (38%) |
| Died in ICU, | 4 (22) |
| Discharged from ICU, | 13 (72) |
Therapies received at any time during the index ICU admission. High‐flow nasal cannula was used with a maximum of 30 L/min flow.
Based on a censor date of 23 April 2020. ICU, intensive care unit.